However, some of our research results contrasted with the findings reported in another study by Camblor et al., which found that certain variants in the NF‐κB genes (NFKB1, NFKBIA, and NFKBIZ) may increase the risk of developing severe COVID‐19. The gene discussed is NFKBIZ; the disease is COVID-19.